Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma

International Journal of Cancer

Volumn 117, Issue 6, 2005, Pages 1013-1019

  Engels, Eric A ^a   Rollison, Dana E ^b   Hartge, Patricia ^a   Baris, Dalsu ^a   Cerhan, James R ^c   Severson, Richard K ^d   Cozen, Wendy ^e   Davis, Scott ^f   Biggar, Robert J ^a   Goedert, James J ^a   Viscidi, Raphael P ^g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c Mayo Clinic   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BK virus; Case control study; Epidemiology; JC virus; Non hodgkin lymphoma

Indexed keywords

ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN G ANTIBODY; PREDNISONE; VINCRISTINE; VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; BK VIRUS; CANCER CHEMOTHERAPY; CHROMOSOME DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN TISSUE; JC VIRUS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OPTICAL DENSITY; POLYOMA VIRUS; PRIORITY JOURNAL; SEROPREVALENCE; URINE; VIRUS INFECTION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS SHEDDING;

ADULT; AGED; ANTIBODIES, VIRAL; BK VIRUS; DNA, VIRAL; FEMALE; HIV INFECTIONS; HOMOSEXUALITY; HUMANS; IMMUNOGLOBULIN G; JC VIRUS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); POLYMERASE CHAIN REACTION; REGISTRIES; SEER PROGRAM; UNITED STATES; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 28044446990     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21277     Document Type: Article

References (27)

1. Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DWG, Miller E. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003;71:115-23.
2. Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J. Seroepidemiology of the human polyomaviruses. J Gen Virol 2003;84:1499-504.
3. Minor P, Pipkin P, Jarzebek Z, Knowles W. Studies of neutralizing antibodies to SV40 in human sera. J Med Virol 2003;70:490-5.
4. Major EO. Human polyomavirus. In: Knipe DM, Howley PM, eds. Fields virology. 4th ed. Philadelphia: Lippincott, Williams, and Wilkins, 2001. p 2175-96.
5. Shah KV. Polyoma viruses (JC virus, BK virus, and simian virus 40) and human cancer. In: Goedert JJ, ed. Infectious causes of cancer: targets for intervention. Totowa, NJ: Humana, 2000. p 461-4.
6. Scherr PA, Mueller NE. Non-Hodgkin's lymphomas. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention.2nd ed. New York: Oxford University Press, 1996. p 920-45.
7. Gallia GL, Houff SA, Major EO, Khalili K. Review: JC virus infection of lymphocytes-revisited. J Infect Dis 1997;176:1603-9.
8. Ricciardiello L, Baglioni M, Giovannini C, Pariali M, Cenacchi G, Ripalti A, Landini MP, Sawa H, Nagashima K, Frisque RJ, Goel A, Boland R, et al. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 2003;63:7256-62.
9. Neel JV, Major EO, Awa AA, Glover T, Burgess A, Traub R, Curfman B, Satoh C. Hypothesis: "Rogue cell"-type chromosomal damage in lymphocytes is associated with infection with the JC human polyoma virus and has implications for oncogenesis. Proc Nat Acad Sci USA 1996;93:2690-5.
10. Viscidi RP, Rollison DEM, Viscidi E, Clayman B, Rubalcaba E, Daniel R, Major EO, Shah KV. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 2003;10:278-85.
11. de Sanjose S, Shah KV, Domingo-Domenech E, Engels EA, Fernandez de Sevilla A, Alvaro T, Garcia-Villanueva M, Romagosa V, Gonzalez-Barca E, Viscidi RP. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer 2003;104:522-4.
12. Engels EA, Chatterjee N, Cerhan JR, Davis S, Cozen W, Severson RK, Whitby D, Colt JS, Hartge P. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004;111:76-80.
13. Engels EA, Viscidi RP, Galloway DA, Carter JJ, Cerhan JR, Davis S, Cozen W, Severson RK, de Sanjose S, Colt JS, Hartge P. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst 2004;96:1368-74.
14. Wilson WH, Grossbard ML, Pittaluga S, Cole D, Pearson D, Drbohlav N, Steinberg SM, Little RF, Janik J, Gutierrez M, Raffeld M, Staudt L, et al. Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficiency. Blood 2002;99:2685-3.
15. Goedert JJ, Biggar RJ, Melbye M, Mann DL, Wilson S, Gail MH, Grossman RJ, DiGioia RA, Sanchez WC, Weiss SH, Blattner WA. Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA 1987;257:331-4.
16. Shah KV, Daniel RW, Strickler HD, Goedert JJ. Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J Infect Dis 1997;176:1618-21.
17. Amlot PL, Green L. Serum immunoglobulins G, A, M, D and E concentrations in lymphomas. Br J Cancer 1979;40:371-9.
18. Lapes M, Rosenzweig M, Barbieri B, Joseph RR, Smalley RV. Cellular and humoral immunity in non-Hodgkin's lymphoma. Correlation of immunodeficiencies with clinicopathologic factors. Am J Clin Pathol 1977;67:347-50.
19. Lafon M-E, Dutronc H, Dubois V, Pelligrin I, Barbeau P, Ragnaud J-M, Pellegrin J-L, Fleury HJA. JC virus remains latent in peripheral blood B lymphocytes but replicates actively in urine from AIDS patients. J Infect Dis 1998;177:1502-5.
20. Reiss K, Khalili K. Viruses and cancer: lessons from the human polyomavirus, JCV. Oncogene 2003;22:6517-23.
21. Lazutka JR, Neel JV, Major EO, Dedonyte V, Mierauskine J, Slapsyte G, Kesminiene A. High titers of antibodies to two human polyomaviruses, JCV and BKV, correlate with increased frequency of chromosomal damage in human lymphocytes. Cancer Lett 1996;109:177-83.
22. del Valle L, Enam S, Lara C, Miklossy J, Khalili K, Gordon J. Primary central nervous system lymphoma expressing the human neurotropic polyomavirus, JC virus, genome. J Virol 2004;78:3462-9.
23. Martini F, Dolcetti R, Ferreri AJM, Ponzoni M, Fumagalli L, Reni M, Terreni MR, Mariuzzi L, Tognon M. No association between polyomaviruses and primary central nervous system lymphomas of HIV-seronegative and HIV-positive patients. Cancer Epidemiol Biomarkers Prev 2004;13:1819-20.
24. Murray JM, Morgello S. Polyomaviruses and primary central nervous system lymphomas. Neurology 2004;63:1299-301.
25. Khalili K, del Valle L, Otte J, Weaver M, Gordon J. Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene 2003;22:5181-91.
26. Galloway DA, McDougall JK. The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature 1983;302:21-4.
27. Ambinder RF. Gamma herpesviruses and "hit-and-run" oncogenesis. Am J Pathol 2000;156:1-3.